Abstracts tagged "survey"

Abstract Number: 0656 • ACR Convergence 2021
A Survey Based Descriptive Study to Assess the Quality of Sleep in Rheumatic Patients
Kezia Sam¹, David Lans² and Fulvia Milite¹, ¹White Plains Hospital, White Plains, NY, ²New York Medical College, Valhalla, NY, New Rochelle, NY
Background/Purpose: Sleeping difficulties although common in rheumatic patients, have often been overlooked presuming it to be part of a chronic illness. We conducted a survey-based…
Abstract Number: 1164 • ACR Convergence 2021
A Survey of Treatment Satisfaction with Intravenous Immunoglobulin Among Patients with Inflammatory Myositis
Alan Zhou, Nancy Maltez and Catherine Ivory, University of Ottawa, Ottawa, ON, Canada
Background/Purpose: Intravenous Immunoglobulin (IVIg) is used to treat rheumatic conditions such as Inflammatory Myositis. Subcutaneous Immunoglobulin (SCIg) is an alternative route of administering Immunoglobulin. Studies…
Abstract Number: 039 • 2020 Pediatric Rheumatology Symposium
Assessing Patient Self-Reported Transition Readiness in a Large Pediatric Rheumatology Center
Priyanka Moolchandani ¹, Alexander Alexander ¹, Cristina Saez ¹, JaLeen Rogers ², Ariel Coleman ², Anne Dykes ², Miriah Gillispie-Taylor ³ and Tiphanie Vogel¹, ¹Baylor College of Medicine, Houston, ²Texas Children's Hospital, Houston, ³Levine Children's Hospital, Charlotte
Background/Purpose: Patients with childhood-onset rheumatologic diseases live well into adulthood and need effective transition from pediatric to adult medical providers. Fortunately, predictors of successful transition…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].